# Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit

> **NCT00844831** · PHASE4 · COMPLETED · sponsor: **University of Louisville** · enrollment: 25 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Lubiprostone

## Key facts

- **NCT ID:** NCT00844831
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844831, "Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00844831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
